StockData
Nuo Therapeutics, Inc. logo

Nuo Therapeutics, Inc. (AURX) stock

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $60.99MP/E –Yield –

Nuo Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Nuo Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -38.7%. For fiscal 2025 it was -75.8%, against -170.2% the year before. The highest annual figure on record is -48.4% in fiscal 2011.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-75.8%+94.4
FY2024Dec 31, 2024-170.2%+351.0
FY2023Dec 31, 2023-521.2%+2304.4
FY2022Dec 31, 2022-2825.6%−2008.2
FY2019Dec 31, 2019-817.4%−704.9
FY2018Dec 31, 2018-112.5%+1964.9
FY2017Dec 31, 2017-2077.4%−1618.6
FY2015Dec 31, 2015-458.8%−215.5
FY2014Dec 31, 2014-243.3%−68.3
FY2013Dec 31, 2013-175.0%+12.4
FY2012Dec 31, 2012-187.4%−139.0
FY2011Dec 31, 2011-48.4%+125.9
FY2010Dec 31, 2010-174.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-15.7%+77.1
Q1 FY2026Mar 31, 2026-47.5%+106.5
Q4 FY2025Dec 31, 2025-52.7%+73.0
Q3 FY2025Sep 30, 2025-52.1%+103.7
Q2 FY2025Jun 30, 2025-92.8%+55.3
Q1 FY2025Mar 31, 2025-154.0%+148.1
Q4 FY2024Dec 31, 2024-125.8%+205.7
Q3 FY2024Sep 30, 2024-155.9%+184.6
Q2 FY2024Jun 30, 2024-148.1%+589.8
Q1 FY2024Mar 31, 2024-302.2%+1098.4
Q4 FY2023Dec 31, 2023-331.5%+965.1
Q3 FY2023Sep 30, 2023-340.4%+2045.9
Q2 FY2023Jun 30, 2023-737.8%−1919.9
Q1 FY2023Mar 31, 2023-1400.6%−1240.6
Q4 FY2022Dec 31, 2022-1296.6%−209.2
Q3 FY2022Sep 30, 2022-2386.4%−653.2
Q4 FY2019Dec 31, 20191182.1%+1136.7
Q3 FY2019Sep 30, 2019-160.0%+89.7
Q2 FY2019Jun 30, 2019-1087.5%−660.8
Q1 FY2019Mar 31, 2019-1733.2%−1314.1
Q4 FY2018Dec 31, 201845.4%+4094.4
Q3 FY2018Sep 30, 2018-249.7%+599.2
Q2 FY2018Jun 30, 2018-426.7%+1647.6
Q1 FY2018Mar 31, 2018-419.1%+560.8
Q4 FY2017Dec 31, 2017-4049.1%−2964.8
Q3 FY2017Sep 30, 2017-848.9%–
Q2 FY2017Jun 30, 2017-2074.3%–
Q1 FY2017Mar 31, 2017-979.8%–
Q3 FY2016Sep 30, 2016-1084.3%–

More Nuo Therapeutics figures

See a number that looks wrong?